Paper: Autonomous AI-based drug prescribing rife with potential problems

“With AI rapidly being deployed in health care, a “move fast and break things” mentality has permeated the industry, raising complex questions about the role of the U.S. Food and Drug Administration in regulating these technologies, says law professor Sara Gerke.

Summary generated from the RSS feed of University of Illinois News Bureau. All article rights belong to the original publisher. Click through to read the full piece on news.illinois.edu.